CFCThe Compounder Score
ISRG logo

ISRG — Intuitive Surgical, Inc.

Medical Instruments & SuppliesHealthcare

$443.59

+$3.70 (+0.84%)

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung.

Market Cap

$153.77B

Forward P/E

35.6x

52-Week Range

$332.02$592.85

ISRG Price History

Current price

$443.59

ISRG return (1Y)

-21.6%

S&P 500 return (1Y)

+12.2%

vs S&P 500

-33.8 pts

Revenue vs. Net Income

$10.1B

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$2.5B

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

16.0%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

7.8x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

5.4%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+0.2%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).